What is Yili Chuanning Biotechnology Co.,Ltd.'s (301301.SZ) StockRank?

MoatMap's StockRank for Yili Chuanning Biotechnology Co.,Ltd. (301301.SZ) is 46/100, with a Hold signal. This is a composite score combining Quality (61), Value (38), and Momentum (38) factor ranks across MoatMap's 19,000+ stock universe.

Does Yili Chuanning Biotechnology Co.,Ltd. have an economic moat?

Yili Chuanning Biotechnology Co.,Ltd. (301301.SZ) has a Quality factor score of 61/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Yili Chuanning Biotechnology Co.,Ltd. a buy, hold, or sell?

MoatMap's current signal for Yili Chuanning Biotechnology Co.,Ltd. (301301.SZ) is Hold, based on a StockRank of 46/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Yili Chuanning Biotechnology Co.,Ltd. in?

Yili Chuanning Biotechnology Co.,Ltd. (301301.SZ) operates in the Healthcare sector, specifically the Biotechnology industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

301301.SZ

HOLDAPPROVE

Yili Chuanning Biotechnology Co.,Ltd. · Healthcare · China · $2.9B · Avg Vol: $12M/d

StockRank

P/E (TTM)

33.0x

ROE

7.2%

D/E

0.1x

Dividend %

2.0%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Yili Chuanning Biotechnology is a dominant, low-cost producer of antibiotic intermediates utilizing massive biological fermentation scale. It is rapidly transitioning into high-margin synthetic biology products. As global pharma seeks secure, scaled, and localized bio-manufacturing partners, Chuanning's regulatory-approved scale creates an un-copyable cost moat with massive pricing power.

COMPANY DESCRIPTION

Yili Chuanning Biotechnology Co., Ltd., a subsidiary of Kelun Pharmaceutical, is a global leader in the production of antibiotic intermediates through biological fermentation. The company utilizes Xinjiang's abundant agricultural resources and low energy costs to achieve unmatched economies of scale in producing erythromycin and cephalosporin intermediates. Its competitive moat is defined by its massive production capacity, advanced fermentation technology, and highly efficient environmental waste treatment systems.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	565M	713M	851M	682M	6.5%
EPS	0.03	0.06	0.09	0.05	17.4%
Shares	2.2B	2.2B	2.2B	2.2B	+0.3%
Debt	483M	286M	211M	175M	-28.6%
Equity	917M	1.0B	1.2B	1.2B	9.2%
Op CF	102M	191M	265M	81M	-7.4%
Inv CF	-8M	-52M	-16M	-34M	—
Fin CF	70M	-267M	-201M	-100M	—

PRICE (1M)-14.2%

SMA 50SMA 200

$1.27

RSI (14)

33.7

52W High

$1.92

From 52W High

0.7%

SCORE BREAKDOWN

Quality

ROIC

11.2%76.6

ROE

7.2%63.4

GP/Assets

10.6%26.9

Op. Margin

14.1%73.5

FCF/Assets

5.1%71.1

Piotroski

—83.5

Int. Cover

28.8x78.8

D/E Ratio

0.15x58.6

Current Ratio

2.57x46.8

Value

P/E (TTM)

33.0x33.8

EV/EBITDA

14.8x27.9

P/FCF

252.4x31.9

P/B

2.3x49.3

P/S

4.3x44.9

Div Yield

2.0%50.6

Momentum

52W High %

66%50.0

RS 6M

-22%51.9

SMA 50/200

0.91x37.2

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

-62%6.7

FUNDAMENTALS

Market Cap

$2.9B

P/E (Forward)

—

Gross Margin

24.9%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 301301.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
301301.SZ	Yili Chuanning Biotechnology Co.,Ltd.(you)	$2.9B	46	HOLD
9969.HK	InnoCare Pharma Limited	$2.6B	48	HOLD
600161.SS	Beijing Tiantan Biological Products Co., Ltd.	$4.0B	47	HOLD
688319.SS	Chengdu Olymvax Biopharmaceuticals Inc.	$2.1B	45	HOLD
2162.HK	Keymed Biosciences Inc.	$2.3B	41	HOLD
600201.SS	Jinyu Bio-technology Co., Ltd.	$1.9B	48	HOLD
688222.SS	HitGen Inc.	$1.8B	47	HOLD
2696.HK	Shanghai Henlius Biotech, Inc.	$4.8B	44	HOLD
301207.SZ	Hualan Biological Vaccine Inc.	$1.6B	47	HOLD
688278.SS	Xiamen Amoytop Biotech Co., Ltd.	$3.4B	59	HOLD

Peer medians: ROE 4.7% · P/E 27.6x · Gross margin 53.1%

Yili Chuanning Biotechnology Co.,Ltd. (301301.SZ) — Stock Score Summary

Yili Chuanning Biotechnology Co.,Ltd. (301301.SZ) has a MoatMap StockRank of 46/100 based on Quality (61/100), Value (38/100), and Momentum (38/100) factor scores. The current signal is HOLD. Yili Chuanning Biotechnology is a dominant, low-cost producer of antibiotic intermediates utilizing massive biological fermentation scale. It is rapidly transitioning into high-margin synthetic biology products. As global pharma seeks secure, scaled, and localized bio-manufacturing partners, Chuanning's regulatory-approved scale creates an un-copyable cost moat with massive pricing power.

Key Financial Metrics

Price	$1.27
Market Cap	$2.9B
P/E (TTM)	33.00
Price/Book	2.34
Return on Equity	7.2%
Return on Invested Capital	11.2%
Debt/Equity	14.83
Gross Margin	24.9%
Operating Margin	14.1%
Revenue Growth	-15.6%
Dividend Yield	2.0%
Free Cash Flow	$12M

Yili Chuanning Biotechnology Co.,Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Yili Chuanning Biotechnology Co.,Ltd.’s (301301.SZ) StockRank?: MoatMap’s StockRank for Yili Chuanning Biotechnology Co.,Ltd. (301301.SZ) is 46/100, with a Hold signal. It is a composite of Quality (61), Value (38), and Momentum (38) factor ranks across MoatMap’s 19,000+ stock universe.
Does Yili Chuanning Biotechnology Co.,Ltd. have an economic moat?: Yili Chuanning Biotechnology Co.,Ltd. (301301.SZ) has a Quality factor score of 61/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Yili Chuanning Biotechnology Co.,Ltd. a buy, hold, or sell?: MoatMap’s current signal for Yili Chuanning Biotechnology Co.,Ltd. (301301.SZ) is Hold, based on a StockRank of 46/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Yili Chuanning Biotechnology Co.,Ltd. in?: Yili Chuanning Biotechnology Co.,Ltd. (301301.SZ) operates in the Healthcare sector, specifically the Biotechnology industry (China).